REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

SLU-PP-332 Dosage and Protocols

SLU-PP-332 dosage protocols reported in published research, plus reconstitution and storage.

RE
Compiled from published research · Last updated 2026-08-18T00:00:00.000Z

Research Protocol Range

Research-vendor products are commonly dosed at 25-50mg subcutaneous once daily. Since no human trial exists, this range reflects informal research-community convention extrapolated from mouse dosing, not validated human guidance.

Reported protocol doses

Standard dose25–50 mg
Frequency1x daily
Routessubcutaneous

Reconstitution

A 50mg vial with 2mL of bacteriostatic water is the pairing reported most often. 50mg vial + 2mL bacteriostatic water = 25mg/mL.

Work out your own concentration with the reconstitution calculator.

Doses shown are those reported in published research, not a recommendation.

References

  1. SLU-PP-332 pan-ERR agonist metabolic syndrome study · Billon C, et al. · 2024
All SLU-PP-332 sections

SLU-PP-915

longevity & healthspanDgrade

The first orally-active pan-ERR agonist — raised exercise capacity in mice even when dosed orally, where its predecessor SLU-PP-332 needed injection.

Thymosin Alpha-1

longevity & healthspanAgrade

A 28-amino-acid thymic peptide approved in 35+ countries as Zadaxin for immune support — but never FDA-approved in the United States.

Oxytocin

longevity & healthspanBgrade

A naturally occurring nonapeptide — FDA-approved as Pitocin for labor, and separately studied off-label (intranasal) for social bonding and stress research.

Put the whole protocol
in one place.

Download nowGet Now